FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 118 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $82,000 | +4000.0% | 5,700 | +35.7% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 4,200 | +1378.9% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 284 | -41.3% | 0.00% | – |
| Q2 2019 | $1,000 | -98.8% | 484 | -96.4% | 0.00% | -100.0% |
| Q1 2019 | $85,000 | +203.6% | 13,384 | +178.8% | 0.01% | +200.0% |
| Q4 2018 | $28,000 | +2700.0% | 4,800 | -20.0% | 0.00% | – |
| Q3 2018 | $1,000 | -85.7% | 6,000 | -7.7% | 0.00% | -100.0% |
| Q2 2018 | $7,000 | -79.4% | 6,500 | +145.2% | 0.00% | -66.7% |
| Q1 2018 | $34,000 | -73.2% | 2,651 | -76.2% | 0.00% | -40.0% |
| Q4 2017 | $127,000 | +3.3% | 11,124 | +46.6% | 0.01% | +25.0% |
| Q3 2017 | $123,000 | -30.1% | 7,587 | -51.3% | 0.00% | -33.3% |
| Q2 2017 | $176,000 | +30.4% | 15,571 | -3.9% | 0.01% | 0.0% |
| Q1 2017 | $135,000 | -72.6% | 16,205 | +55.3% | 0.01% | -66.7% |
| Q4 2016 | $493,000 | +1132.5% | 10,434 | +259.7% | 0.02% | +800.0% |
| Q3 2016 | $40,000 | -72.0% | 2,901 | -37.1% | 0.00% | -75.0% |
| Q2 2016 | $143,000 | -74.2% | 4,613 | -85.9% | 0.01% | -78.4% |
| Q1 2016 | $555,000 | +48.0% | 32,815 | -32.8% | 0.04% | +76.2% |
| Q4 2015 | $375,000 | – | 48,845 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|